INSTI is trusted by healthcare professionals globally with over 15 million tests already performed. The INSTI platform provides accurate results in 1 minute, where other competing products require 20 minutes to days for their results.
Marketed since 2006, the INSTI HIV assay has received regulatory approvals by US FDA, Health Canada, European Union CE Marking and WHO prequalification.
Marketed since 2016, the INSTI HIV Self Test provides an at-home testing solution for consumers that prefer the convenience and privacy of a home test. It has received regulatory approvals by European Union CE Marking and UNITAID/WHO ERP-D status. It is available to a growing number of countries that have changed their policies to allow home testing.
Marketed since 2015, the multiplex assay is a powerful tool in populations where HIV and syphilis co-infection is a concern. One sample, one minute, two results.